Cell and Gene Therapy Products

Articles containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer to a human recipient. Gene therapies are novel and complex products that can offer unique challenges in product development. Hence, ongoing communication between the FDA and stakeholders is essential to meet these challenges. Gene therapy products are being developed around the world, the FDA is engaged in a number of international harmonization activities in this area.

Examples: Musculoskeletal tissue, skin, ocular tissue, human heart valves; vascular graft, dura mater, reproductive tissue/cells, Stem/progenitor cells ,somatic cells, Cells transduced with gene therapy vectors , Combination products (e.g., cells or tissue + device)

Related conferences: International Conference on Clinical And Molecular Genetics, 28-30 November 2016 (Chicago, USA); 6th International Conference on Genomics & Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress on Human Genetics, 31October – 02November 2016 (Valencia, Spain); International Conference on Genetic Counselling And Genomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell & Gene Therapy Congress, 19-21 May 2016 ( San Antonio, USA); 2015 Midwest Conference on Cell Therapy & Regenerative Medicine September 18-19 2015 (Kansas City, Missouri); 2nd Cell & Gene Therapy Conference 9-10 September 2015 (Philadelphia, United States); Cell & Gene Therapy Europe 29-30 September 2015 (Barcelona, Spain); Cell Manufacturing and  Gene Therapy Congress 2015 2-3 December 2015 (Brussels, Belgium). 

Gene therapy products often initially appear promising because they reflect strong scientific rationale when they are proposed as treatments for specific, well-defined genetic disorders. In addition, some gene therapy products have been well publicized because they offer hope for the treatment of rare, disabling, or life-threatening disorders. Despite strong scientific rationale and publicity-generated enthusiasm, the field has not yet produced any products that have gone through clinical development and provided the evidence of safety and effectiveness. ommercial-scale manufacturing of cell-based therapies requires substantial infrastructure – a manufacturing facility setup for controlled production, skilled staff with expertise including cell therapy-specific manufacturing strategies, technology, and regulatory requirements.

  • Cellular immuno therapy products
  • Cellular & gene therapy products
  • Allogeneic & autologous therapy products
  • Cell based therapy products
  • Tissue based products

Related Conference of Cell and Gene Therapy Products

March 5-7, 2018

20th Global Congress on Biotechnology

Park Inn by Radisson Hotel London, UK
May 09-10, 2018

11th World Congress on Cell & Tissue Science

Tokyo, Japan
May 14-15, 2018

World Congress on Cell and Structural Biology

Osaka Japan
May 21-23, 2018

6th International Conference on Integrative Biology

Barcelona, Spain
June 04-06, 2018

12th Annual Conference on Stem Cell and Regenerative Medicine

Prague, Czech Republic
July 2-3, 2018

4th International Conference on Bioscience

Vienna, Austria
July 23-24, 2018

Annual Biotechnology Congress

Vancouver, British Columbia, Canada
September 3-4, 2018

World Congress on Stem Cell Biology and Biobanking

Tokyo, Japan
September 10-11, 2018

22nd Global Biotechnology Congress

Stockholm, Sweden
September 17-18, 2018

International Podiatry Conference

Dubai, UAE
September 19 - 20, 2018

2nd Annual summit on Cell Signaling and Cancer Therapy

Philadelphia, Pennsylvania, USA
September 19 - 20, 2018

2nd Annual summit on Cell Metabolism and Cytopathology

Philadelphia, Pennsylvania, USA
September 20-21, 2018

6th Annual Congress on Biology and Medicine of Molecules

Abu Dhabi, UAE
September 20-21, 2018

Tissue Repair and Regeneration Congress

Dubai, UAE
September 21-22, 2018

11th International Conference on Genomics and Pharmacogenomics

Philadelphia, Pennsylvania, USA
September 21-22, 2018

5th International Conference on Human Genetics and Genetic Disorders

Philadelphia, Pennsylvania, USA
October 24-25, 2018

24th Biotechnology Congress: Research & Innovations

Boston, Massachusetts, USA
October 24-25, 2018

Annual Congress on CRISPR-Cas9 Technology

Boston, USA
November 2-3, 2018

International Congress & Expo on Genomics and Bioinformatics

Columbus, Ohio, USA
November 9-10, 2018

2nd Annual Summit on Cell Therapy and Stem Cell Research

Atlanta, Georgia, USA
November 9-10, 2018

2nd Annual Summit on Cell Therapy and Regenerative Medicine

Atlanta, Georgia, USA
Dec 03-04, 2018

3rd World Biotechnology Congress


(10 Plenary Forums - 1Event)
Sao Paulo, Brazil

Cell and Gene Therapy Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in